Adalimumab vs Candesartan

## Adalimumab vs Candesartan: Overview

This comparison examines the pharmacological differences between **Adalimumab** and **Candesartan**.

## Mechanism of Action

**Adalimumab**: Fully human anti-TNF-alpha monoclonal antibody.

**Candesartan**: Prodrug hydrolyzed to active form; selective angiotensin II type 1 receptor blocker.

## Pharmacokinetics

**Half-life**: Adalimumab — 14 days; Candesartan — 9 hours.

## Chemical Properties

**Molecular Formula**: Adalimumab — N/A; Candesartan — C33H34N6O6.

**Molecular Weight**: Adalimumab — N/A; Candesartan — 610.6640 g/mol.

**Type**: Adalimumab — Antibody; Candesartan — Small molecule.